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Backgrormd. Ccmmy Row reserve masurements we useful 
in Mment of the physiologic significance of coronary lesions. 
liowever, animal studies uggest that alterations in hemodynamic 
status may inEuence cemnary flow resew independent of cow- 
nary stelmsts. 
Mefbodr. Coronary flow ~esprve was measured uring cardiac 
c~tbeterizatiw ith the use of a 3F coronary Doppler catheter and 
intramronary pqwerine. Flow reserve was measured under 
contml conditiar and during incrws in heart rate produced by 
atrial pa&g (18 patients] or dnrhtg elevntion of arterial pressure 
by inlrawnons phenylephrine infusion (9 patients] with intrwr- 
wary alpha-adrenergic blnehade by phentolamine. 
Resrrfrs. Coronary flow reserve progrcsstwly decreased fmm 
3.7 i 0.9 (mean f SD) at the rate of 71 f B kals/min al rest to 
3.0 i 0.6 durtng pacing at 100 katslmin rrod to 2.6 * 0.5 during 
pndns at 120 beatimin. Flow reserw &ueased because of a 
progre!slve increase io rest roronary flow velocity during pacing 
The measurement of coronary blood flow reserve using 
maximal pharmacologic vasodilation has been employed to 
asseas the physiologic signiticance of coronary stenoces 1 IL 
as well as evaluate the results of coronary angioplasty (2) 
and coronary bypass surgery (3). A limitation to the use of 
coronary flow reserve in these settings is that faclors altering 
rest or maximal coronary flow independent of coronary 
stenosis may affect measured flow reserve (4-6). Hemody- 
namic status (heart rate [7,8], arterial pressure 19-I I] con- 
tractility [12] and preload [13]), letI ventricular bypertropby 
(14). myocardial ittf?.retion (15) and pharmacologic agents 
(16) have been demonstrated to influence indexes of coro- 
nary flow reserve in animals. 
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was 101 a&&d by the blood prrau~ kc 
4.3 + 1.0, phrnykpbrine 4.4 “- 1.5, phcay 
tarnine 4.4 f 2.0). 
Conclmkms. Sudden incream in hew rate but mt 
Coronary Row reserve measurement in awake humans 
during cardiac catheterizatioo with the use of a coronary 
Do,>pter catheter was pioneered by Wilson and associates 
(17.18). These investigators studied the effect of changes in 
heart rate and arterial pressure on coronary Row reserve in 
rardiac transplant recipients (19). Coronary flaw reserve was 
reduced during pacing tachycardia but was uttaEected by 
elevation in arterial pressure produced by isometric hand- 
@%. 
The applicability of these studies performed in patients 
with transplanted and largely uninervated hearts to other 
patients is uncertain. Significant alpha-adrenergk neural 
influences on the coronary reactive hyperemia response 
have been observed in animal studies (20). A number of 
morphologic and physiologic aanormalities are uniquely 
present in transplanted hearts. Cardiac allograft vasculopa- 
thy, a pervasive problem after transplantation, involves the 
small coronary arteries and arterioles, as well as large 
epicardial vessels. Coronary intimal proliferation is uni- 
farmly detectable by intravascular ultrasound 1 year after 
transplantation and may be severe when coronary arteries 
are angiographically normal (21). Graft rejection results in 
impairment of large artery and resistance vessel dilator 
responses (22,23). Endothelium-dependent coronary vasodi- 
lation, as assessed by acetylchoiine infusion, is impaired in 
transplanted hearts (24) and sensitivity to beta-adrenergic 
agonists i  increased (25). The current study was performed 
to assess the influence of increases in heart rate and arterial 
pressure on coronary flow rese~ye in patients who were 
routinely referred for diagnostic cardiac catheterization and 
were free of these potenrially confounding factors. 
Methods 
Study group. Patients undergoing elective coronary arte- 
riography for the evaluation of chest pain were considered 
for study if angiography revealed a nonstenotic coronary 
artery that was anatomically suitable for placement of a 
coronary Doppler catheter and there was no evidence of left 
ventricular dysfunction. The study group consisted of Xl 
men and 7 women with a mean age of 51 + I1 years. 
Single-vessel coronary disease (diameter stenosis >SO%) 
was present in two patients and two-vessel disease in one 
patient. The left anterior descending coronary artery was 
studied in 17 patients and the left circumflex coronary artery 
in IO. The research protocol was approved by the University 
of Iowa Institlltionrd Review Board, and written informed 
consent for the research protocol was obtained from each 
subject before cardiac catheterization. 
Coronary flow reserve measurement. A 7F or 8F coronary 
angioplasty guiding catheter was positioned at the coronary 
ortium, and a 0.014-in. (0.036 cm) coronary angioplasty 
guide wire wns advanced into the coronary artery to be 
studied. A 3F ZO-MHz coronary Doppler catheter (NuMed) 
was advanrzd over the guide wire into the proximal vessel 
and positimed to obtain ahigh quality pbasic signal of blood 
flow velor ity. The pulsed Doppler meter (Bioengineering 
Department, University of Iowa Hospitals and Clinics) was 
range-gated to maximize the amplitude of the mean corooary 
blood flow velocity signal. Phasic and mean coronary blood 
flow velocity (kHz shift), mean arterial pressure obtained 
fram the guiding catheter, hear? rate and the elcctrocardio. 
gram (ECG) were continuously recorded on a multichannel 
recorder. After measurement of coronary blood flow veloc- 
ity at rest, a bolus dose of 6 to IO mg of papaverine 
hydrochloride (2 mdml of 0.9% saline solution) was injected 
through the guiding catheter into the coronary ostium, and 
the resultant increase in coronary blood flow velocity was 
reccrded. To confirm that a dose of papaverine produced 
maximal hyperemia, coronary blood flaw velocity was re- 
corded during administration of an additional papaverine 
dose 2 tc 4 mg larger than the prior dose. Flow velocity was 
allowed to return to baseline levels between doses of papav- 
e;ine. Coronary Row reserve was calculated as the quotient 
of the peak mean tlow velocity (kHz shift) after intracoro- 
nary papaverine and the rest mean flow velocity during the 
IS to 30 s preceding papaverine administration. Coronary 
flow reserve measurcmcnt was repeated after hemodynamic 
interventions using the largest dose of intracoronary papas- 
erine adminis&md during baseline coronary ROW reserve 
measurement. 
Experbnenlal protoml. Subjects were brought to the car- 
diac catheterization laboratory in a fasting state. Prescribed 
medications were continued on the day of the research 
study. Diiepm (5 to IC mg intravenously or orally) was 
given for sedation. No subject received atropine prcmcdica- 
tion. The study was performed during intravenous infusion 
of nitroglycerin at 8 p&in to avoid catheter-induced coro- 
nary m~erf spasm and obviate papa&ac-induced dilation 
of the proximal coronary artery, which would influence the 
relation between changes in coronary flow velocity and 
coronary blood flow. 
Alrerarion in hearl rare. The effect of increases in heart 
rate on coronary flow reserve was assessed in 18 patients. A 
6F bipolar pacemaker was positioned at the high right 
atrium. After measurement of coronary Row reserve and 
arterial pressure during sinus rbythm, these variables wore 
remeasured after 2 min of atrial pacing at 120 beatslmin in 
nine patients and after pacing at 100 and 120 beats/min in 
nine patients. 
Alieration in arrerialpressure. The effect of increases in 
arterial pressure on coronary ffow reserve was assessed in 
nine patients. A 6F bipolar pacemake; was positioned in the 
high right atrium, and pacing was performed at 5 to 
10 beatslmin above the rest sinus rate to prevent reflex 
cardiac slowing during elevation of arterial pressure. Coro- 
nary flow reserve and arterial pressure were measured under 
control conditions and after elevation in blood pressure by 
intravenous infusion of phenylephrine. Phenylephrine was 
infused at an initial rate of 20 &min and adjusted upward 
over a period of 5 to 10 min to Produce a target increase in 
mean arterial pressure of 30 mm Hg. In animal experiments 
assessing the effect of increased arterial pressure oo coro- 
nary Row reserve, a smaller increase in coronary flow during 
maximal vasodilation was observed when arterial pressure 
was increased with methoxamine compared with aorlic 
constriction (IO). To minimize any limitation to coronary 
flow resulting From direct effects of alpha-adrenoceptor 
stimulation on the coronary circulation, measurements were 
repeated in seven patients after regional alpha-adrenergic 
blockade with intracoronary phentolamine, 1 to 2 mg given 
over 3 min while phenylephrine was continued. 
Data analysis. Data are expressed as mean value f SD. 
Study variables before and after interventions were com- 
pared by using a two.way analysis of variance for repeated 
measures with assessment of intergroup differences by 
Scheffe F test or the Student I test for paired measurements. 
Statistical significance was assumed at p < 0.05. 
Results 
Effect of increases in heart rate on earnnary ilaw rerwt. 
Sysrenric bemodynamics. The control heart rate averaged 
71 ? 8 beatsimin in tkr patients who underwent coronary 
Row reserve measurement during sinus rhythm and at paced 

Plgorc 1. Effect of atrial pacing !e&ycardia on coronitry Row 
reserve (CFR) in patienls with normalcontrol flow reserve (Group 1) 
and depressed control Row reserve (Group 2). Abbreviations as in 
Figure 1. 
S). Both rest and papaverhte maximal hyperemia coronary 
blood flow velocities tended to increase during elevation of 
arterial pressure (Fig. 6), but these values were not signifi- 
cantly different from the respective control values. 
Disfmsion 
Assessment of coronary flow reserve can provide clini- 
cally useful information in patients with known or suspected 
ischemic heart disease. However, as recently emphasized by 
IUocke (4) and Hoffman (6), interpretation of flow reserve 
measurements in individual patients is complicated by the 
fact that changes in flow reserve can be produced by several 
factors that alter rest or maximal coronary flow, including 
hemodynamic variables, left ventricular hyr%rtrophy, myo- 
cardial infarction and microvascular disease. Because the 
most commonly used catheter-based methods for assessing 
coronary flow reserve, the coronary Doppler catheter and 
digital videodensitometry, measure changes in coronary 
flow, not absohre volumetric flow, it is impossible to deter- 
mine with these techniques whether a reduction in coronary 
@ate 5. Effect of intravenous phenylephrine (PE) infusion and 
ahenvleuHne combined with intracomnarv ohentolamine WA) on 
mean a&ial pressure (kit axk) and co&&y flow reserve (r&M 
uda). 
Figore 6. Effect of increases in arterial pressure produced by 
intravenous pheaylephrine (PI?) infusion and phenylephrine corn- 
bined with intracomaary phentolamine (PTA) on cornnary blood 
flow velocity at rat and during maximal papaverine-induced by- 
peremia. Comnary bh?od flow v&-city values arc normalized to the 
control rest velocity. 
flow reserve represents a true limitation in maximal low or 
an increase in rest flow. 
In the oresent studv we assessed the effect of increases in 
heart rate or arterial pressure on coronary flow reserve in 
conscious patients during cardiac catheterization. The he 
modynamic interventions were relatively pu-mean atie- 
rial pressure was unchanged during heart rate increases and 
heart rate was held constant by atrial pacing during elevation 
of arterial pressure. Coronary flow reserve decreased pro- 
gessively as heart rate was increased, and a significant 
reduction in flow reserve was observed with alterations in 
rate within the normal range. The reductln?! in .:or .‘nury Row 
reserve during pacing was due entirely to an increase in 
coronary flow velocity at rest; maximal flaw velocity was 
unchanged during pacing. In contrast, coronary Row reserve 
was not affected by elevations in arterial pressure that 
resulted in a similar increase in rate-mean pressure product 
observed during pacing. These findings are similar to those 
reported by McGinn et al. (19) in heart transplant recipients. 
In that study, the increase in mean arterial pressure 
during isometric handgrip in transplant recipients was asso- 
ciated with an increase in both rest and hyperemic flow 
velocity. Because both velocities increased proportionally, 
coronary flow reserve was unchanged. In the present study 
there was no significant change in rest or maximal coronary 
Row velocity when arterial pressure was increased by phe- 
nylephrine. 
Ther.? are several possible explanations for these findings. 
‘Ihe dose of phentolatnitte used in the present SW ’ may 
have incompletely reversed adrenerglcally mediated coro- 
nary vasoconstriction that prevented the expected increase 
in coronary Row. An intracaronary dose of phentolamine of 
2 to 3 mg has been shown to reverse exercise.induced 
coronary vasoconstriction (26). constriction of coronary 
resistance vessels by intracoronary pheaylephrine (27) and 
cocaine-induced epicardiai vasoconstriction (28). In our 
study phentolamine was discontinued if arterial pressure 
began to decrease and the average dose was 1.4 ? 0.5 rug. 
We cannot exclude the possibility that a higher dose may 
have been necessary to completely nverse coronary vaso- 
constriction during phenylephrine infusion. In the study of 
McGinn et al. (19), performed in recipients of a denervated 
heart, circulating norepinephrine levels did not rise during 
isometric handgrip. and neither reflex nor humoral sympa- 
thetic vasoconstriction would be expected. 
Enlargement of the coronary artery at the site of Doppler 
flow velocity measurement during phenylepbrine-induced 
hypertension may have resulted in an underestimation of 
changes in volumetric coronary blood flow by flow velocity 
measurements. If the 38% increase in arterial pressure 
during phenylephrine infusion caused just a 5% increase in 
coronary diameter, coronary blood flow could have in- 
creased by ICrZ w*ith no change in flow velocity. In fact, 
cyclic changes incoronary diameter of 5% to IO% occur with 
phasic changes in aortic pressure during the cardiac cycle 
(29.30). It is possible that smaller changes in arterial caliber 
during blood pressure elevation occurred in the transplant 
recipients studied by McGinn et al. (19) because of de- 
creased arterial compliance related to the intimal thickening 
tha: accompanies cardiac allograft vasculopathy. 
Llmitathms of the study. The present study has several 
limitations. I) The elevations in heart rate and arterial 
pressure were brief in duration. More sustained alterations 
in these variables cou!d produce different effects on coro- 
nary flow reserve. For example, chronic systemic hyperten- 
sion can result in left ventricular hypertrophy and coronary 
arteriolar changes, or both, that reduce coronary flow re- 
serve (31). 2) Changes in rest heart rate or arterial pressure 
caused by the direct and r&x effects of cardiac medications 
might influence coronary flow reserve to a greater or lesser 
degree than changes due to atrial pacing or phenylephrine. 
For example, antianginal agents with negative inotmpic 
effects could lower myocardial oxygen demand, with a 
resultant reduction in flow at rest, and could decrease 
ttansmural compressive forces with a consequent increase in 
maximal hyperemic flow. The quantitative effect of these 
influences on coronary flow reserve at any given heart rate is 
unknown. 3) The highest arterial pressure achieved with 
phenylephrine infusion (130 + g mm Hg) is still within the 
range of autoregulation: greater elevations may have a 
different effect on coronary flow reserve. When the upper 
limit of autoregulation is exceeded in dogs, flow at rest 
increases more than maximal flow and flow reserve begins to 
decrease (IO). 4) We cannot predict from our study the 
quantitative effect of reductions in heart rate or arterial 
pressure on flow reserve. 
Implicalfens. Our findings and those of M&inn et al. (19) 
indicate that the “normal” range of coronary Row reserve 
will vary, depending on the heart rate at the time of Row 
reserve measurement. McGinn et al. (19) suggested measur- 
ingflow reserve at a paced rate of 100 beatsimin to eliminate 
this source of variability. When f?ow reserve is measured by 
noninvasive techniques, such as positron emission tomogra- 
phy. control of heart rate is less feasible. Extrapo!atioa of 
the measured flow reserve to that expected at a stand&i& 
heart rate might improve the usefulness of these measure- 
ments. Even ifthe effect of heart rate could bc eliminated or 
cot-rectcd, the infiuetlce of other hemodyaamic factors such 
as contractility (12) and preload (13,19) on coronary Row 
reserve would still limit the interpretation of flow reserve 
measurements in individual patients. With further advatws 
in technology. it may eventually bc possible to measure 
indexes of coronary vascular reserve that are independent of 
hemodynamic variables (11). 
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